Genotyping Assay Market to Reach $94.61 Billion by 2029, Growing at a CAGR of 23%

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Genotyping Assay Industry By The Forecast Year 2029?

The size of the genotyping assay market has expanded significantly in recent times. It is forecast to rise from $33.98 billion in 2024 to $41.31 billion in 2025, achieving a compound annual growth rate (CAGR) of 21.6%. The historical growth of this market is attributable to traditional glassware usage, cultural and lifestyle influences, economic factors, hospitality and foodservice industry growth, and gift and decor trends.

The genotyping assay market is projected to experience substantial expansion in the coming years. By 2029, its valuation is anticipated to reach $94.61 billion, demonstrating a compound annual growth rate (CAGR) of 23.0%. This forecasted increase is driven by factors such as customization and personalization, emerging health and wellness trends, the expansion of e-commerce, the development of smart and functional glassware, and culinary and mixology trends. Significant developments expected during this period involve advancements in material innovation, novel shapes and designs, the introduction of smart glassware, specialized glassware tailored for beverages, and enhanced health and safety features.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13444&type=smp

What Are The Top Growth Drivers Impacting The Genotyping Assay Market Outlook?

The expanding occurrence of genetic disorders is projected to boost the genotyping assay market moving forward. These medical conditions stem from anomalies or alterations within an individual’s deoxyribonucleic acid (DNA). Genotyping assays work by contrasting the DNA of individuals affected with these conditions against that of healthy individuals to identify discrepancies, thereby uncovering particular genetic mutations or variations associated with a specific genetic disorder. For example, in June 2023, Gene People, a UK-based registered charity organization supporting individuals with genetic conditions, stated that one in every 25 children in the UK was affected by a genetic disorder, impacting around 30,000 newborns and young children in the nation, alongside over 2.4 million children and adults annually. Consequently, the rising incidence of genetic disorders is fueling the expansion of the genotyping assay market.

What Are The Segment Types Shaping The Genotyping Assay Market?

The genotyping assaymarket covered in this report is segmented –

1) By Product And Service: Reagents And Kits; Genotyping Services; Instruments; Bioinformatics

2) By Technology: Microarrays; Polymerase Chain Reaction; Sequencing; Capillary Electrophoresis; Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry; Other Technologies

3) By End-User: Pharmacogenomics; Personalized Medicine And Diagnostics; Animal Genetics; Agricultural Biotechnology; Research And Diagnostic Laboratories; Academic Institutes

Subsegments:

1) By Reagents And Kits: DNA Extraction Kits; PCR Reagents; SNP Genotyping Kits; Genotyping Services; Genotyping by PCR; Whole Genome Sequencing Services; SNP Genotyping Services

2) By Instruments: PCR Machines; Sequencing Instruments; Microarrays

3) By Bioinformatics: Data Analysis Software; Genotyping Data Management Tools

What Are The Major Trends Driving The Growth Of The Genotyping Assay Market?

Leading companies in the genotyping assay market are making progress in genomic research, including the development of CE-IVD marked assays to identify HIV-1 strains resistant to treatment. The CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit functions as a Sanger sequencing-based assay that examines positive human immunodeficiency virus (HIV) samples to detect genetic variations that could lead to resistance against common antiretroviral therapies. As an illustration, in January 2023, Thermo Fisher Scientific, a US-based firm, released the CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit. This system is designed to detect treatment-resistant strains of HIV-1 and incorporates distinctive features such as assessing genomic mutations, utilizing HIV RNA, identifying drug resistance mutations, employing gold-standard Sanger sequencing technology, and is intended for clinical use. The availability of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit has offered advantages by enhancing the detection of treatment-resistant HIV-1 strains, supplying ready-to-use reagents and controls, fulfilling regulatory demands, exhibiting high-performance characteristics, and being compatible with existing sequencing platforms and workflows.

Which Leading Players Are Enhancing Their Genotyping Assay Market Presence Worldwide?

Major companies operating in the genotyping assay market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv Inc., Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., Integrated DNA Technologies Ltd., Sequenom Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies PLC, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs, TrimGen Corporation, Xcelris Genomics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Genotyping Assay Market?

North America was the largest region in the genotyping assay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Genotyping Assay Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13444&type=smp

Browse Through More Reports Similar to the Global Genotyping Assay Market 2025, By The Business Research Company

Immunofluorescence Assay Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

Neuroscience Antibodies And Assays Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuroscience-antibodies-and-assays-global-market-report

Stem Cell Assay Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795